RedHill Biopharma Ltd. (NASDAQ:RDHL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Roni Mamluk Other companies: Ayala Pharmaceuticals Inc (President & CEO, Director · May 7, 2020 – Jan 19, 2023 · Past); Chiasma Inc (Director · Jul 15, 2015 – Aug 5, 2021 · Past) | Director · Since at least Mar 18, 2026 |
| Abe Schwartz | President and CEO of Schwartz Technologies Corporation · Since at least Nov 4, 2026 |
| Adi Frish | Chief Corporate & Business Development Officer · Since at least Dec 1, 2025 |
| Dror Ben-Asher | Chairman & CEO · Since at least Mar 18, 2026 |
| Gilead Raday | Chief Operating Officer · Since at least Mar 18, 2026 |
| Guy Goldberg | Chief Business Officer · Since at least Mar 18, 2026 |
| Ira Kalfus | Chief Medical Officer · Since at least Nov 4, 2026 |
| Kenneth Reed | Director · Since at least Nov 5, 2026 |
| Mark L. Levitt | Chief Scientific Officer · Since at least Oct 19, 2026 |
| Ofer Tsimchi | Director · Since at least Mar 18, 2026 |
| Patricia Anderson | Senior VP Regulatory Affairs · Since at least Nov 5, 2026 |
| Razi Ingber | CFO · Since at least Mar 18, 2026 |
| Reza Fathi | Senior VP R&D · Since at least Nov 5, 2026 |
| Rick D. Scruggs | President, RedHill Biopharma Inc. & Chief Commercial Officer · Since at least Nov 4, 2026 |
| Shmuel Cabilly | Director · Since at least Mar 18, 2026 |